Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Amson Vaccines & Pharma (Pvt.) Ltd

Private vaccine and pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad-based manufacturer of vaccines, pharmaceutical products and medical consumables.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation22 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date23 Jul 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
AMSON Vaccines & Pharma (Pvt.) Ltd.
Company type
Private vaccine and pharmaceutical manufacturer
Address
Plot No. 154, Industrial Triangle, Kahuta Road, Islamabad 44000, Pakistan · 44000
Phone
+92 51 4491492-3; +92 51 4490359
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000393 116 linked products · source seen 22 Sep 2026 View source ↗
DSL 017/DSL(D)/PS&DC-ICT/2025 8 linked products · source seen 22 Sep 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx135public portfolio records represented
REG104unique registrations represented
IDX123indexed MedInfoBase presentations
SRC12additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR99current validated price records
G57generic molecules in indexed catalogue
DF8dosage-form groups
TA11therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage73%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage95%
priced packs safely normalized per unit
Comparable-market coverage88%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixAmson Vaccines & Pharma (Pvt.) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/amson-vaccines-pharma-pvt-ltdGenerated 23 Sep 2026Anti-infectives49 · 40%Vitamins, minerals & nutrition21 · 17%Vaccines & immunologicals15 · 12%Respiratory & allergy9 · 7%Pain & musculoskeletal7 · 6%Cardiovascular7 · 6%Hematology & thrombosis5 · 4%Other therapeutic areas10 · 8%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioAmson Vaccines & Pharma (Pvt.) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/amson-vaccines-pharma-pvt-ltdGenerated 23 Sep 2026123presentationsTablet68 · 55%Injection27 · 22%Capsule8 · 7%Suspension7 · 6%Vaccine6 · 5%Syrup4 · 3%Other forms3 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionAmson Vaccines & Pharma (Pvt.) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/amson-vaccines-pharma-pvt-ltdGenerated 23 Sep 2026108comparable productsBelow peer median29 · 27%Near peer median40 · 37%Above peer median39 · 36%Company median price position+1.4%Lowest-price equivalents17Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsAmson Vaccines & Pharma (Pvt.) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/amson-vaccines-pharma-pvt-ltdGenerated 23 Sep 2026Mediate Pharmaceutical Pvt Ltd26 shared46% overlapZafa Pharmaceutical Laboratories (P…25 shared44% overlapBosch Pharmaceuticals (Pvt) Ltd.23 shared40% overlapValor Pharmaceuticals23 shared40% overlapNabiqasim Industries (Pvt) Ltd.,22 shared39% overlapMacter International Limited22 shared39% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives49 products · 40%
Vitamins, minerals & nutrition21 products · 17%
Vaccines & immunologicals15 products · 12%
Respiratory & allergy9 products · 7%
Pain & musculoskeletal7 products · 6%
Cardiovascular7 products · 6%
Hematology & thrombosis5 products · 4%
Cross-therapeutic & anti-inflammatory4 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Vitamins / minerals / hematinics20 products · 16%
Vaccines13 products · 11%
Analgesics / NSAIDs7 products · 6%
Antiparasitic medicines6 products · 5%
Antifungals6 products · 5%
Penicillin antibacterials6 products · 5%
Macrolide antibacterials6 products · 5%
Third-generation cephalosporins6 products · 5%
Formulation footprint

Dosage forms

Tablet68 products
Injection27 products
Capsule8 products
Suspension7 products
Vaccine6 products
Syrup4 products
Pessary2 products
Drops1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 AmsonateMethylprednisolone 4presentations 1 g, 125 mg, 40 mg, 500 mg · Injection #2 Amvax BHepatitis B vaccine (recombinant HBsAg) 4presentations 10 mcg/0.5 mL, 20 mcg/1 mL · Injection, Vaccine #3 CesodCeftriaxone 4presentations 1 g, 250 mg, 500 mg · Injection #4 CiproxCiprofloxacin 4presentations 100 mg, 250 mg, 500 mg, 750 mg · Tablet #5 WorexMebendazole 4presentations 100 mg, 500 mg · Tablet #6 AmfluFluconazole 3presentations 150 mg, 50 mg/5 mL · Capsule, Suspension
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2927% of comparable products
Near market median40within ±5% of median
Above market median3936% of comparable products
Lowest-price equivalents17ties included
Company median price position +1.4% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Amsoprin 300 mgAcetylsalicylic acid (Aspirin) · Tablet · 500's PKR 0.38/tablet-88.5% vs market median Amsoprin 300 mgAcetylsalicylic acid (Aspirin) · Tablet · 10x50's PKR 0.41/tablet-87.7% vs market median Irosul 200 mgFerrous sulfate · Tablet · 1000's PKR 0.03/tablet-78.5% vs market median Irosul 200 mgFerrous sulfate · Tablet · 500's PKR 0.03/tablet-77.3% vs market median Fanim-5 5 mgFolic acid · Tablet · 1000's PKR 0.27/tablet-66.6% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 26shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 25shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 23shared generics Valor Pharmaceuticals219 products · 97 generics 23shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 22shared generics Macter International Limited256 products · 93 generics 22shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers96Distinct registrations among indexed, published, presentation-validated products only
Verified price observations123
Products with a verified price123
Products with multiple price observations0
Source records with multiple versions120
Latest portfolio source check22 Sep 2026
Latest effective price date23 Jul 2026
Latest source observation22 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

104 unique registration(s) · 123 indexed presentation(s) · 12 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Ceftapen Ceftazidime 250 mg Injection vial 029059 PKR 194.15 PKR 194.15/vial/unit 21% above median
Ceftapen Ceftazidime 1 g Injection vial 029060 PKR 627.11 PKR 627.11/vial/unit 37% above median
Cesod Ceftriaxone 250 mg Injection vial 113055 PKR 153.35 PKR 153.35/vial/unit 20% below median
Cesod Ceftriaxone 250 mg IV injection 1's 113056 PKR 153.35 PKR 153.35/vial/unit 18% below median
Cesod Ceftriaxone 500 mg IV injection 1 vial 113057 PKR 258.11 PKR 258.11/vial/unit 18% below median
Cesod Ceftriaxone 1 g IV injection 1's 113058 PKR 487.37 PKR 487.37/vial/unit 21% below median
CesodSource observed Ceftriaxone 2 g IV injection 1 vial 113059Official source ↗ No indexed price — —
CesodSource observed Ceftriaxone 2 g IV injection 1 vial 113059Official source ↗ No indexed price — —
Ciprox Ciprofloxacin 250 mg Tablet 10's 017351 PKR 367.99 PKR 36.80/tablet 46% above median
Ciprox Ciprofloxacin 500 mg Tablet 10's 017352 PKR 647.68 PKR 64.77/tablet 51% above median
Ciprox Ciprofloxacin 100 mg Tablet 1x10's 037529 PKR 99.10 PKR 9.91/tablet Near median
Ciprox Ciprofloxacin 750 mg Tablet 1x10's 037530 PKR 396.42 PKR 39.64/tablet Near median
ComBe Five Diphtheria + Tetanus + Pertussis + Hepatitis B + Haemophilus influenzae type b vaccine 25 Lf + 5.5 Lf + 16 IOU + 12.5 mcg HBsAg + 11 mcg Hib PRP per 0.5 mL Vaccine injection 1ml vial (Two dose) 089966 PKR 6,488.61 — No comparator
ComBe FiveSource observed Diphtheria + Tetanus + Pertussis + Hepatitis B + Haemophilus influenzae type b vaccine 30 IU Vaccine injection 2.5 ml vial (Five dose) 089967Official source ↗ No indexed price — —
ComBe FiveSource observed — 30 IU Vaccine injection 5ml vial (Ten Dose) 089968Official source ↗ No indexed price — —
Curoxime Cefuroxime 250 mg Injection 5 vial 029056 PKR 275.69 PKR 55.14/vial/unit Near median
Curoxime Cefuroxime 750 mg Injection vial 029057 PKR 192.27 PKR 192.27/vial/unit Near median
Curoxime Cefuroxime 1.5 g Injection vial 029058 PKR 348.85 PKR 348.85/vial/unit Near median
Damex Cough Aminophylline + Diphenhydramine + Ammonium chloride + Menthol 32 mg + 8 mg + 30 mg + 0.98 mg/5 mL Syrup 120ml 017347 PKR 87.72 PKR 0.73/mL Near median
Damex Cough Aminophylline + Diphenhydramine + Ammonium chloride + Menthol 32 mg + 8 mg + 30 mg + 0.98 mg/5 mL Syrup 60ml 017347 PKR 45.95 PKR 0.77/mL Near median
Damex Cough Aminophylline BP 32 mg/5 mL Syrup 450ml 017347 PKR 311.33 PKR 0.69/mL No comparator
DTwP-rHepB-Hib VaccineSource observed (1 dose Vial) TetanusToxoid 5.5 LF ( 60 IU Injection 1 dose vial containing 0.5ml 077530Official source ↗ No indexed price — —
DTwP-rHepB-Hib VaccineSource observed (1 dose Vial) TetanusToxoid 5.5 LF ( 60 IU Injection 1 dose vial containing 0.5ml 077530Official source ↗ No indexed price — —
Entvir Entecavir 0.5 mg Tablet 3x10's 066594 PKR 19,803.30 PKR 660.11/tablet 85% above median
Euvichol-Plus Cholera vaccine (inactivated, oral; Vibrio cholerae O1 and O139) 1.5 mL dose Oral suspension vaccine 1's Plastic Tube 107916 PKR 1,117.58 — No comparator
Fanim-5 Folic acid 5 mg Tablet 500's 021612 PKR 159.34 PKR 0.32/tablet 60% below median
Fanim-5 Folic acid 5 mg Tablet 100's 021612 PKR 115.09 PKR 1.15/tablet 44% above median
Fanim-5 Folic acid 5 mg Tablet 1000's 021612 PKR 269.25 PKR 0.27/tablet 67% below median
Fefan Ferrous sulfate + Folic acid 150 mg + 0.5 mg Tablet 3x10's 017372 PKR 67.72 PKR 2.26/tablet 42% above median
Fefan Ferrous sulfate + Folic acid 150 mg + 0.5 mg Tablet 1000's 017372 PKR 1,200.83 PKR 1.20/tablet 27% below median
Fefan Ferrous sulfate + Folic acid 150 mg + 0.5 mg Tablet 10x10's 017372 PKR 120.08 PKR 1.20/tablet 27% below median
Fefan DS Ferrous sulfate + Folic acid 300 mg + 5 mg Tablet 3x10's 019670 PKR 270.45 PKR 9.02/tablet 9% below median
Fefan DS Ferrous sulfate + Folic acid 300 mg + 5 mg Tablet 1000's 019670 PKR 9,577.19 PKR 9.58/tablet Near median
Fefan DS Ferrous sulfate + Folic acid 300 mg + 5 mg Tablet 10x10's 019670 PKR 1,018.85 PKR 10.19/tablet 10% above median
Group ACYW135 Meningococcal Polysaccharide Vaccine Meningococcal polysaccharide vaccine, groups A/C/Y/W-135 50 mcg of each A, C, Y and W-135 polysaccharide / 0.5 mL dose Lyophilized powder for injection with diluent 1's vial (Diluent) 115101 PKR 1,292.55 — No comparator
Hemofer Ferrous sulfate + Folic acid 150 mg + 0.5 mg Tablet 1000's 019671 PKR 1,200.83 PKR 1.20/tablet 27% below median
Hemofer Ferrous sulfate + Folic acid 150 mg + 0.5 mg Tablet 100's 019671 PKR 144.09 PKR 1.44/tablet 13% below median
Hyzonate Hydrocortisone 250 mg Powder for injection 1 vial 019226 PKR 251.73 PKR 251.73/vial/unit No comparator
Hyzonate Hydrocortisone 500 mg Injection 1 vial 019227 PKR 566.89 PKR 566.89/vial/unit 58% above median
Hyzonate Hydrocortisone 100 mg Injection 1 vial 019228 PKR 141.72 PKR 141.72/vial/unit 41% above median
Imatet Purified Tetanus Toxoid not less than 40 IU Injection 10x0.5ml 017373 PKR 832.49 PKR 166.50/mL No comparator
IMMUNOHBS Human hepatitis B immunoglobulin 180 IU/mL IM solution for injection 1's Vial 107955 PKR 11,899.64 PKR 11,899.64/vial/unit No comparator
Immunorho Human anti-D immunoglobulin 300 mcg/2 mL (1500 IU) Prefilled syringe injection 1's 111116 PKR 13,534.90 PKR 13,534.90/syringe No comparator
Irosul Ferrous sulfate 200 mg Tablet 500's 021613 PKR 16.98 PKR 0.03/tablet 77% below median
Irosul Ferrous sulfate 200 mg Tablet 100's 021613 PKR 6.79 PKR 0.07/tablet 55% below median
Irosul Ferrous sulfate 200 mg Tablet 1000's 021613 PKR 32.26 PKR 0.03/tablet 78% below median
Levam Levamisole 40 mg Tablet 3x10's 019650 PKR 415.81 PKR 13.86/tablet 24% above median
Loramine Loratadine 5 mg/5 mL Syrup 60ml 029071 PKR 105.05 PKR 1.75/mL Near median
Loramine Loratadine 10 mg Tablet 10's 029072 PKR 141.72 PKR 14.17/tablet Near median
Measles Vaccine Live attenuated (Freeze Dried) Lyophilized injection. Measles Virus Note Less than 1000 CCID50Source observed — — Lyophilized powder for injection 0.5ml vial (Single dose). 052298Official source ↗ No indexed price — —
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Amson Vaccines & Pharma (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/amson-vaccines-pharma-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.